 | • レポートコード：D0804-14759 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、106ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗ウイルス治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗ウイルス治療の種類別市場規模（ヘルペス抗ウイルス薬、肝炎抗ウイルス薬、HIV抗ウイルス薬、インフルエンザ抗ウイルス薬、その他）、用途別市場規模（病院、クリニック、外来手術センター、薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie Inc.、Roche、Merck、GSK、Pfizer、Boehringer Ingelheim、Johnson & Johnson、Beximco Pharmaceuticals、Novartis、Bristol-Myers Squibb Company、Sanofi ・地域別グローバル市場分析 2015年-2020年 ・抗ウイルス治療の北米市場（アメリカ、カナダ、メキシコ） ・抗ウイルス治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗ウイルス治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗ウイルス治療の南米市場（ブラジル、アルゼンチン） ・抗ウイルス治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ヘルペス抗ウイルス薬、肝炎抗ウイルス薬、HIV抗ウイルス薬、インフルエンザ抗ウイルス薬、その他 ・用途別分析：病院、クリニック、外来手術センター、薬局、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Antiviral Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Antiviral Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Antiviral Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Antiviral Therapeutics market has been segmented into:
Herpes Antiviral Drugs
Hepatitis Antiviral Drugs
HIV Antiviral Drugs
Influenza Antiviral Drugs
Others
By Application, Antiviral Therapeutics has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers
Pharmacies
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antiviral Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Antiviral Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antiviral Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Antiviral Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Antiviral Therapeutics Market Share Analysis
Antiviral Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antiviral Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antiviral Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Antiviral Therapeutics are:
AbbVie Inc.
Roche
Merck
GSK
Pfizer
Boehringer Ingelheim
Johnson & Johnson
Beximco Pharmaceuticals
Novartis
Bristol-Myers Squibb Company
Sanofi
1 Antiviral Therapeutics Market Overview
1.1 Product Overview and Scope of Antiviral Therapeutics
1.2 Classification of Antiviral Therapeutics by Type
1.2.1 Global Antiviral Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Antiviral Therapeutics Revenue Market Share by Type in 2019
1.2.3 Herpes Antiviral Drugs
1.2.4 Hepatitis Antiviral Drugs
1.2.5 HIV Antiviral Drugs
1.2.6 Influenza Antiviral Drugs
1.2.7 Others
1.3 Global Antiviral Therapeutics Market by Application
1.3.1 Overview: Global Antiviral Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Pharmacies
1.3.6 Others
1.4 Global Antiviral Therapeutics Market by Regions
1.4.1 Global Antiviral Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Antiviral Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Antiviral Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Antiviral Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antiviral Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Antiviral Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antiviral Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 AbbVie Inc.
2.1.1 AbbVie Inc. Details
2.1.2 AbbVie Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie Inc. SWOT Analysis
2.1.4 AbbVie Inc. Product and Services
2.1.5 AbbVie Inc. Antiviral Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche Antiviral Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Antiviral Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GSK SWOT Analysis
2.4.4 GSK Product and Services
2.4.5 GSK Antiviral Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Antiviral Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boehringer Ingelheim SWOT Analysis
2.6.4 Boehringer Ingelheim Product and Services
2.6.5 Boehringer Ingelheim Antiviral Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Johnson & Johnson SWOT Analysis
2.7.4 Johnson & Johnson Product and Services
2.7.5 Johnson & Johnson Antiviral Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Beximco Pharmaceuticals
2.8.1 Beximco Pharmaceuticals Details
2.8.2 Beximco Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Beximco Pharmaceuticals SWOT Analysis
2.8.4 Beximco Pharmaceuticals Product and Services
2.8.5 Beximco Pharmaceuticals Antiviral Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novartis SWOT Analysis
2.9.4 Novartis Product and Services
2.9.5 Novartis Antiviral Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bristol-Myers Squibb Company
2.10.1 Bristol-Myers Squibb Company Details
2.10.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bristol-Myers Squibb Company SWOT Analysis
2.10.4 Bristol-Myers Squibb Company Product and Services
2.10.5 Bristol-Myers Squibb Company Antiviral Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sanofi
2.11.1 Sanofi Details
2.11.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sanofi SWOT Analysis
2.11.4 Sanofi Product and Services
2.11.5 Sanofi Antiviral Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Antiviral Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Antiviral Therapeutics Players Market Share
3.2.2 Top 10 Antiviral Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Antiviral Therapeutics Revenue and Market Share by Regions
4.2 North America Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Antiviral Therapeutics Revenue by Countries
5.1 North America Antiviral Therapeutics Revenue by Countries (2015-2020)
5.2 USA Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Antiviral Therapeutics Revenue by Countries
6.1 Europe Antiviral Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Antiviral Therapeutics Revenue by Countries
7.1 Asia-Pacific Antiviral Therapeutics Revenue by Countries (2015-2020)
7.2 China Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Antiviral Therapeutics Revenue by Countries
8.1 South America Antiviral Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Antiviral Therapeutics by Countries
9.1 Middle East & Africa Antiviral Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Antiviral Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Antiviral Therapeutics Market Forecast by Type (2019-2024)
10.3 Herpes Antiviral Drugs Revenue Growth Rate (2015-2025)
10.4 Hepatitis Antiviral Drugs Revenue Growth Rate (2015-2025)
10.5 HIV Antiviral Drugs Revenue Growth Rate (2015-2025)
10.6 Influenza Antiviral Drugs Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Antiviral Therapeutics Market Segment by Application
11.1 Global Antiviral Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Antiviral Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.6 Pharmacies Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Antiviral Therapeutics Market Size Forecast (2021-2025)
12.1 Global Antiviral Therapeutics Market Size Forecast (2021-2025)
12.2 Global Antiviral Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Antiviral Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Antiviral Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Antiviral Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Antiviral Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Antiviral Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Antiviral Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antiviral Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antiviral Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Antiviral Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AbbVie Inc. Corporate Information, Location and Competitors
Table 6. AbbVie Inc. Antiviral Therapeutics Major Business
Table 7. AbbVie Inc. Antiviral Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. AbbVie Inc. SWOT Analysis
Table 9. AbbVie Inc. Antiviral Therapeutics Product and Solutions
Table 10. AbbVie Inc. Antiviral Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Roche Corporate Information, Location and Competitors
Table 12. Roche Antiviral Therapeutics Major Business
Table 13. Roche Antiviral Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Roche SWOT Analysis
Table 15. Roche Antiviral Therapeutics Product and Solutions
Table 16. Roche Antiviral Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Merck Corporate Information, Location and Competitors
Table 18. Merck Antiviral Therapeutics Major Business
Table 19. Merck Antiviral Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Merck SWOT Analysis
Table 21. Merck Antiviral Therapeutics Product and Solutions
Table 22. Merck Antiviral Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. GSK Corporate Information, Location and Competitors
Table 24. GSK Antiviral Therapeutics Major Business
Table 25. GSK Antiviral Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. GSK SWOT Analysis
Table 27. GSK Antiviral Therapeutics Product and Solutions
Table 28. GSK Antiviral Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Pfizer Corporate Information, Location and Competitors
Table 30. Pfizer Antiviral Therapeutics Major Business
Table 31. Pfizer Antiviral Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Pfizer SWOT Analysis
Table 33. Pfizer Antiviral Therapeutics Product and Solutions
Table 34. Pfizer Antiviral Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 36. Boehringer Ingelheim Antiviral Therapeutics Major Business
Table 37. Boehringer Ingelheim Antiviral Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Boehringer Ingelheim SWOT Analysis
Table 39. Boehringer Ingelheim Antiviral Therapeutics Product and Solutions
Table 40. Boehringer Ingelheim Antiviral Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Johnson & Johnson Corporate Information, Location and Competitors
Table 42. Johnson & Johnson Antiviral Therapeutics Major Business
Table 43. Johnson & Johnson Antiviral Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Johnson & Johnson SWOT Analysis
Table 45. Johnson & Johnson Antiviral Therapeutics Product and Solutions
Table 46. Johnson & Johnson Antiviral Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Beximco Pharmaceuticals Corporate Information, Location and Competitors
Table 48. Beximco Pharmaceuticals Antiviral Therapeutics Major Business
Table 49. Beximco Pharmaceuticals Antiviral Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Beximco Pharmaceuticals SWOT Analysis
Table 51. Beximco Pharmaceuticals Antiviral Therapeutics Product and Solutions
Table 52. Beximco Pharmaceuticals Antiviral Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Novartis Corporate Information, Location and Competitors
Table 54. Novartis Antiviral Therapeutics Major Business
Table 55. Novartis Antiviral Therapeutics Total Revenue (USD Million) (2017-2018)
Table 56. Novartis SWOT Analysis
Table 57. Novartis Antiviral Therapeutics Product and Solutions
Table 58. Novartis Antiviral Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bristol-Myers Squibb Company Corporate Information, Location and Competitors
Table 60. Bristol-Myers Squibb Company Antiviral Therapeutics Major Business
Table 61. Bristol-Myers Squibb Company Antiviral Therapeutics Total Revenue (USD Million) (2017-2018)
Table 62. Bristol-Myers Squibb Company SWOT Analysis
Table 63. Bristol-Myers Squibb Company Antiviral Therapeutics Product and Solutions
Table 64. Bristol-Myers Squibb Company Antiviral Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Sanofi Corporate Information, Location and Competitors
Table 66. Sanofi Antiviral Therapeutics Major Business
Table 67. Sanofi Antiviral Therapeutics Total Revenue (USD Million) (2017-2018)
Table 68. Sanofi SWOT Analysis
Table 69. Sanofi Antiviral Therapeutics Product and Solutions
Table 70. Sanofi Antiviral Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Antiviral Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 72. Global Antiviral Therapeutics Revenue Share by Players (2015-2020)
Table 73. Global Antiviral Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Antiviral Therapeutics Revenue Market Share by Regions (2015-2020)
Table 75. North America Antiviral Therapeutics Revenue by Countries (2015-2020)
Table 76. North America Antiviral Therapeutics Revenue Market Share by Countries (2015-2020)
Table 77. Europe Antiviral Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Antiviral Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Antiviral Therapeutics Revenue by Countries (2015-2020)
Table 80. South America Antiviral Therapeutics Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Antiviral Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Antiviral Therapeutics Revenue Market Share by Countries (2015-2020)
Table 83. Global Antiviral Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 84. Global Antiviral Therapeutics Revenue Share by Type (2015-2020)
Table 85. Global Antiviral Therapeutics Revenue Forecast by Type (2021-2025)
Table 86. Global Antiviral Therapeutics Revenue by Application (2015-2020)
Table 87. Global Antiviral Therapeutics Revenue Share by Application (2015-2020)
Table 88. Global Antiviral Therapeutics Revenue Forecast by Application (2021-2025)
Table 89. Global Antiviral Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Antiviral Therapeutics Picture
Figure 2. Global Antiviral Therapeutics Revenue Market Share by Type in 2019
Figure 3. Herpes Antiviral Drugs Picture
Figure 4. Hepatitis Antiviral Drugs Picture
Figure 5. HIV Antiviral Drugs Picture
Figure 6. Influenza Antiviral Drugs Picture
Figure 7. Others Picture
Figure 8. Antiviral Therapeutics Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Ambulatory Surgical Centers Picture
Figure 12. Pharmacies Picture
Figure 13. Others Picture
Figure 14. Global Antiviral Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Antiviral Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Antiviral Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Antiviral Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Antiviral Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Antiviral Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Antiviral Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Antiviral Therapeutics Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Antiviral Therapeutics Revenue Market Share in 2019
Figure 23. Global Top 10 Players Antiviral Therapeutics Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Antiviral Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Antiviral Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 27. Global Antiviral Therapeutics Revenue Market Share by Regions in 2018
Figure 28. North America Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. Europe Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. South America Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. North America Antiviral Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 34. North America Antiviral Therapeutics Revenue Market Share by Countries in 2019
Figure 35. USA Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. Canada Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. Europe Antiviral Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Antiviral Therapeutics Revenue Market Share by Countries in 2019
Figure 40. Germany Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. UK Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. France Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Russia Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. Italy Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Antiviral Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Antiviral Therapeutics Revenue Market Share by Countries in 2019
Figure 47. China Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. Japan Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. Korea Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. India Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. South America Antiviral Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 53. South America Antiviral Therapeutics Revenue Market Share by Countries in 2019
Figure 54. Brazil Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Antiviral Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Antiviral Therapeutics Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. UAE Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Antiviral Therapeutics Revenue and Growth Rate (2015-2020)
Figure 62. Global Antiviral Therapeutics Revenue Share by Type (2015-2020)
Figure 63. Global Antiviral Therapeutics Revenue Share by Type in 2019
Figure 64. Global Antiviral Therapeutics Market Share Forecast by Type (2021-2025)
Figure 65. Global Herpes Antiviral Drugs Revenue Growth Rate (2015-2020)
Figure 66. Global Hepatitis Antiviral Drugs Revenue Growth Rate (2015-2020)
Figure 67. Global HIV Antiviral Drugs Revenue Growth Rate (2015-2020)
Figure 68. Global Influenza Antiviral Drugs Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Antiviral Therapeutics Revenue Share by Application (2015-2020)
Figure 71. Global Antiviral Therapeutics Revenue Share by Application in 2019
Figure 72. Global Antiviral Therapeutics Market Share Forecast by Application (2021-2025)
Figure 73. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 74. Global Clinics Revenue Growth Rate (2015-2020)
Figure 75. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 76. Global Pharmacies Revenue Growth Rate (2015-2020)
Figure 77. Global Others Revenue Growth Rate (2015-2020)
Figure 78. Global Antiviral Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Antiviral Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Antiviral Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Antiviral Therapeutics Revenue Market Forecast (2021-2025)
Figure 82. Europe Antiviral Therapeutics Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Antiviral Therapeutics Revenue Market Forecast (2021-2025)
Figure 84. South America Antiviral Therapeutics Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Antiviral Therapeutics Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
新抗ウイルス薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Novel Antiviral Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Novel Antiviral Drugs m…- 直接作用型抗ウイルス薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Direct-acting Antiviral Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Direct-acting A…
- 抗肝炎ウイルス薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti Hepatitis Virus Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 皮膚科処方用治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Prescription Dermatology Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2% in the forecast period of 2020 to 2025 and will expected to reach USD 32930 million by 2025, from USD 26930 million in 2019. The …
- 閉経後膣萎縮症（PVA）治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Postmenopausal Vaginal Atrophy (PVA) Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market player…